Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
A new phase III trial for a novel glucose-regulating therapy, GLP-1R agonist X-21, has been published in the Journal of Clinical Endocrinology & Metabolism, showing a 42% reduction in HbA1c ... Read More
Continuous Coverage
President Donald Trump and Iranian President Masoud Pezeshkian signed a memorandum of understanding Thursday to end hostilities in…
A’ja Wilson is shooting 42% from three in the playoffs, a career-high mark that has become the statistical…
California State Senator Michael Young, a Democrat who represented the 12th District for nearly two decades and served…
Zaccharie Risacher faces a critical juncture in his professional career following an inaugural NBA campaign that fell short…
Hollywood is quietly shrinking the roles of Latino immigrants in U.S. television, a shift that could reshape the…
South Korean food conglomerates, including SPC Group’s Paris Baguette and Daesang Corp (KRX: 001680), are diversifying their Q3…
Global Affairs
US and Iran Sign Landmark De-escalation Agreement to Halt Middle East Conflict United States and Iranian officials signed…
Markets And Money
SpaceX (NASDAQ: SPAC) shares rebounded 9.3% on June 17, 2026, marking their first gain since the IPO, while…
Digital Culture
SK Telecom lost White House-approved access to Anthropic’s Claude Mythos model after U.S. officials flagged potential China-linked data…
Science And Wellbeing
A study published this week reveals that the Zika virus replicates and persists in fetal brains and placentas,…
Screen And Sound
Donald Trump urged Israeli Prime Minister Benjamin Netanyahu to adopt a “softer touch” in Lebanon during a late…
Fixtures And Form
PREM Rugby extends Defender partnership through 2027, Arsenal partners with Saint Lucia Tourism Authority, and Wrexham signs Nex…
